Eli Lilly’s injectable blood sugar drug, tirzepatide, which is currently being s...
Amgen has discontinued both of its mid-stage lupus programs due to a lack of eff...
Astellas Pharma has announced the acquisition of Iveric Bio for $5.9 billion, ba...
Sun Pharmaceutical Industries Ltd., an Indian firm, has been directed by the U.S...
Pfizer recently announced that its pneumococcal conjugate vaccine, Prevnar 20, h...
The FDA has granted conditional approval to a novel ALS medication, a move that ...
The FDA has approved Seres Therapeutics’ microbiome capsule, Vowst, to prevent t...
Despite winds blowing against the biotechnology industry in recent months, Orbit...
Eli Lilly has officially ended its collaboration with Nektar Therapeutics on the...
Novartis is eliminating its pipeline the old-fashioned way. The Swiss pharmaceut...
Revolo Biotherapeutics believes that it possesses the data necessary to continue...
Roche’s antibody drug Polivy has been given the green light by the Food and Drug...
GSK has decided to pay $2 billion in cash to acquire Canadian-based medicine dev...
Biotech firm Moderna has released comprehensive data from mid-stage research on ...
Eli Lilly’s mirikizumab, an IL-23 inhibitor, has recently been rejected by the F...
Illumina has entered into a joint agreement with Henry Ford Health to analyze th...
